Penumbra Inc Receivables Turnover Ratio (PEN), from the third quarter 2026 to the third quarter 2025 current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Penumbra Inc  (NYSE: PEN)
 

Penumbra Inc Accounts Receivables Turnover Ratio from the third quarter 2026 to the third quarter 2025

Quarterly Results, Trends, Rankings, Statistics


Penumbra Inc's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the third quarter 2026 to a ratio of 8.22, above the company average. This is a clear sign of healthy business climate in the Medical Equipment & Supplies industry and improving liquidity at their respective customers, during the third quarter 2026. Average receivable collection period, for the Penumbra Inc in Sep 30 2026 quarter, has decreased to 44 days, compared to 45 days, in the Jun 30 2026 quarter.

If we take a look into Healthcare sector 168 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Sep 30 2026 from 689 to 1583.

What is Receivable Turnover Ratio?
What is Penumbra Inc Selling?


What is Receivable Turnover Ratio?




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

PEN Receivables Turnover Ratio (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Receivable Change 6.43 % 8.47 % 9.12 % 13.33 % 4.19 %
Y / Y Revenue Change 15.64 % 14.9 % 15.62 % 22.14 % 17.82 %
Receivable Turnover Ratio (TTM) 8.22 8.06 7.94 7.83 7.68
PEN's Total Ranking # 1583 # 689 # 1039 # 1529 #
Accounts Receivable average collection period days 44 45 46 47 48
Seq. Receivable Change 2.53 % 3.88 % -3.54 % 3.59 % 4.5 %
Seq. Revenue Change 5.15 % 4.08 % -2.76 % 8.66 % 4.49 %


Receivable Turnover Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 50
Healthcare Sector # 169
Overall Market # 1583

Receivable Turnover Ratio Statistics
High Average Low
13.27 6.33 4.5
(Dec 31 2015)   (Mar 31 2023)





PEN Company Profile • Back to PEN Efficiency Comparisons • Compare PEN Receivables Turnover Ratio to its Competitors

Financial Statements
Penumbra Inc's Accounts Receivable $ 195 Millions Visit PEN's Balance sheet
Penumbra Inc's Sales TTM $ 1,560 Millions Visit PEN's Income Statement
Sources of PEN's Revenues Visit PEN's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Equipment & Supplies Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
PEN's Receivable Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
PEN's Growth Rates PEN's Roa PEN's Inventory Turnover Ratio PEN's Dividend Comparisons
PEN's Profitability Ratios PEN's Roi PEN's Asset Turnover Ratio PEN's Dividend Growth
PEN's Valuation Ratios PEN's Roe PEN's Financial Strength Ratios PEN's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Sep 30 2026, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Sep 30 2026 Receivable at quarter ending Sep 30 2026
Biogen Inc   15.19 $ 10,297.300  Millions$ 677.900  Millions
Iqvia Holdings Inc   10.43 $ 17,311.000  Millions$ 1,659.500  Millions
Axogen inc   8.71 $ 266.926  Millions$ 30.654  Millions
Ensign Group Inc  8.62 $ 5,674.305  Millions$ 658.477  Millions
Intuitive Surgical Inc   7.44 $ 12,115.600  Millions$ 1,629.350  Millions
Quest Diagnostics Inc  7.43 $ 11,841.000  Millions$ 1,593.250  Millions
Beta Bionics Inc   7.15 $ 127.899  Millions$ 17.897  Millions
Angiodynamics Inc   7.13 $ 323.784  Millions$ 45.418  Millions
Medpace Holdings Inc   6.73 $ 2,838.385  Millions$ 421.525  Millions
3m Company  6.59 $ 25,247.000  Millions$ 3,832.500  Millions
Healthcare Services Group Inc   6.36 $ 1,879.860  Millions$ 295.784  Millions
Integra Lifesciences Holdings Corp  6.26 $ 1,656.786  Millions$ 264.861  Millions
Neogen Corporation  6.17 $ 884.120  Millions$ 143.371  Millions
Mimedx Group Inc   6.06 $ 303.363  Millions$ 50.077  Millions
Avantor Inc   5.98 $ 6,635.600  Millions$ 1,110.300  Millions
Conmed Corporation  5.76 $ 1,369.288  Millions$ 237.544  Millions
Clearpoint Neuro Inc   5.75 $ 45.493  Millions$ 7.906  Millions
Johnson and Johnson  5.45 $ 99,335.000  Millions$ 18,233.000  Millions
Biomerica Inc   5.17 $ 4.338  Millions$ 0.838  Millions
Ge Healthcare Technologies Inc   5.11 $ 19,878.000  Millions$ 3,886.750  Millions
Bausch and Lomb Corp  4.68 $ 5,418.000  Millions$ 1,158.500  Millions
Orthopediatrics Corp  4.61 $ 263.665  Millions$ 57.191  Millions
Cryo cell International Inc   4.54 $ 31.127  Millions$ 6.851  Millions
Glaukos Corp  4.47 $ 578.355  Millions$ 129.301  Millions
Medinotec Inc   4.05 $ 10.211  Millions$ 2.524  Millions

Date modified: 2026-10-30T06:27:05+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.